Mark Teague is the Chief Financial Officer of BioMotiv with primary responsibility for planning, implementing, managing, and controlling all finance, human resources, and administration functions. He has more than twenty years of leadership experience in investment banking, private equity and venture capital at both the fund and portfolio operating company management levels.
Prior to joining BioMotiv, Mr. Teague was the CFO of Neuros Medical, Inc., a development stage neuromodulation medical device company. During his tenure on the executive team, the company completed several rounds of fundraising and was awarded multiple grants, using the proceeds from both to complete product development and initiate first-in-man, pilot, and pivotal clinical studies.
As the Managing Director and principal of Venture Management Solutions Group, Mr. Teague provided management consulting services to technology start-ups in the areas of general management, fundraising, finance, administration, and operations.
Prior to that, Mr. Teague was the CEO of The Colonnade Corporation, a private equity investment firm he founded. Colonnade acquired seven small manufacturing businesses in which he served as a shareholder, board member, and a variety of interim management roles before successfully selling these businesses to strategic and financial buyers. Previously, Mr. Teague was on the corporate finance team for a regional investment bank where he originated and executed initial public offerings, mergers and acquisitions, leveraged buyouts, and private placements of debt and equity.
Mr. Teague earned a BS degree in Industrial Engineering from Northwestern University and an MBA degree from University of Virginia. He is a long-standing member of the Board of Directors of some local human service non-profit organizations.